Condition
Rheumatoid Arthritis-Associated Interstitial Lung Disease
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Unknown2
Clinical Trials (4)
Showing 4 of 4 trials
NCT07484243Recruiting
Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis
NCT01776398Recruiting
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
NCT06184893UnknownPrimary
Rheumatoid Arthritis-associated Interstitial Lung Disease Definition
NCT05979454UnknownPrimary
Value of KL-6 in Rheumatoid Arthritis-Associated ILD
Showing all 4 trials